These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7692009)

  • 1. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
    J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
    Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
    Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
    Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
    J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
    Figueredo-Cardenas G; Chen Q; Reiner A
    Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
    Beal MF; Ferrante RJ; Swartz KJ; Kowall NW
    J Neurosci; 1991 Jun; 11(6):1649-59. PubMed ID: 1710657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.
    Brouillet E; Jenkins BG; Hyman BT; Ferrante RJ; Kowall NW; Srivastava R; Roy DS; Rosen BR; Beal MF
    J Neurochem; 1993 Jan; 60(1):356-9. PubMed ID: 8417157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
    Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
    Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Nitropropionic acid toxicity in the striatum.
    Wüllner U; Young AB; Penney JB; Beal MF
    J Neurochem; 1994 Nov; 63(5):1772-81. PubMed ID: 7523600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
    Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
    Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular perfusion of rat brain nuclei using microdialysis: a method for studying differential neurotransmitter release in response to neurotoxins.
    Reynolds NC; Lin W; Cameron CM; Roerig DL
    Brain Res Brain Res Protoc; 1999 Jul; 4(2):124-31. PubMed ID: 10446406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.
    Brouillet E; Hantraye P; Ferrante RJ; Dolan R; Leroy-Willig A; Kowall NW; Beal MF
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7105-9. PubMed ID: 7624378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteic acid lesions in rat striatum spare somatostatin-neuropeptide Y (NADPH-diaphorase) neurons.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ
    Neurosci Lett; 1990 Jan; 108(1-2):36-42. PubMed ID: 1689475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM; Hilt DC
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
    Nakao N; Brundin P
    Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
    Sun Z; Xie J; Reiner A
    Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.